The Ministry of Health and Community Protection warned of fake and contaminated medical products used to treat hepatic venous obstruction, and called on all health facilities and health-care practitioners in the private sector to take the necessary steps to protect patients from their harm.
The ministry issued a circular, which addressed it to all health facilities, and health-care practitioners in the private sector, to warn against "Defitelio" Defibrotide 200mg Vials of 2.5ml (80 mg / ml) Solution for Infusion ", which is used to treat venous obstruction. Hepatic, after the World Health Organization has reported that deformed injection bottles of 200 mg imitation have been found in Australia, Saudi Arabia, and Latvia, and it has been confirmed that these counterfeit products do not contain the active substance of the product as they are contaminated with mildew “Cladosporium sp” and “Aspergillus niger”. », And the reports received have proven that the two products are imitated in terms of their identity, composition and source.
The original manufacturer GENTIUM SRL confirmed that the manufacturers were not manufactured at its factory, and the original 200-mg defibrotide drug with batch number 0286 was exported to Argentina, Hong Kong, Malaysia, Singapore and Turkey, and the original 200-mg defibrotide medication with batch number 0126 was exported to Australia, Jordan, Kuwait, Lebanon, New Zealand, Qatar and Singapore Turkey and the United Arab Emirates, and it is important for all countries to inspect and verify the existence of counterfeit products, regardless of where these products were found, and stressed that the two operations should not be used if available.